Analyst Price Targets — CLBT
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| May 26, 2026 8:28 pm | — | D.A. Davidson | $20.00 | $12.89 | TheFly | Cellebrite initiated with a Buy at DA Davidson |
| May 15, 2026 1:44 pm | — | Needham | $15.00 | $13.03 | TheFly | Cellebrite price target lowered to $15 from $18 at Needham |
| February 12, 2026 1:39 pm | Eric Martinuzzi | Lake Street | $21.00 | $13.86 | TheFly | Cellebrite price target lowered to $21 from $23 at Lake Street |
| February 12, 2026 1:38 pm | — | UBS | $23.00 | $13.85 | TheFly | Cellebrite price target lowered to $23 from $25 at TD Cowen |
| February 12, 2026 12:18 pm | — | Needham | $18.00 | $14.26 | TheFly | Cellebrite price target lowered to $18 from $24 at Needham |
| October 23, 2024 9:09 am | Tomer Zilberman | Bank of America Securities | $20.00 | $18.11 | TheFly | Cellebrite price target raised to $20 from $17 at BofA |
| September 25, 2024 8:53 am | Jeff Van Rhee | Craig-Hallum | $23.00 | $16.87 | TheFly | Cellebrite price target raised to $23 from $20 at Craig-Hallum |
| August 16, 2024 8:50 am | Eric Martinuzzi | Loop Capital Markets | $17.00 | $16.15 | StreetInsider | Cellebrite (CLBT) PT Raised to $17 at Lake Street Capital Markets |
| August 16, 2024 6:59 am | Tomer Zilberman | Bank of America Securities | $17.00 | $14.96 | TheFly | Cellebrite price target raised to $17 from $13 at BofA |
| April 1, 2024 8:41 am | Jeff Van Rhee | Craig-Hallum | $16.00 | $11.08 | TheFly | Cellebrite price target raised to $16 from $14 at Craig-Hallum |
Latest News for CLBT
Hogan's non-discretionary sale satisfied tax withholding obligations from vesting RSUs. He retains 590,777 shares worth $9.25 million.
The partnership unifies what happens in the sky with what's stored on the drone in a single investigative workflow TYSONS CORNER, Va. and PETAH TIKVA, Israel, July 8, 2026 /PRNewswire/ -- Cellebrite DI Ltd.
Cellebrite (CLBT) remains a buy as fundamentals strengthen, with FedRAMP High achieved and federal demand reaccelerating. Q2 ARR guidance of $510–513M implies 22–23% growth, supporting a narrative of renewed momentum post-federal softness. Platform adoption advances, with Inseyets conversions near 60% and growth products now 14% of ARR, lengthening CLBT's growth runway.
Cellebrite DI Ltd. (CLBT) Discusses AI Technology and Innovation in Tech Talk Transcript
Reduces investigative workloads from weeks to minutes accelerating investigations like never before TYSONS CORNER, Va. and PETAH TIKVA, Israel, June 10, 2026 /PRNewswire/ -- Cellebrite DI Ltd.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for CLBT.
U.S. House Trading
No House trades found for CLBT.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.